Cell IDx’s UltraPlex platform technology provides everything you need for multiplexed IHC-based immune-profiling of tissue biomarkers. One technology from
research to clinical — from staining to analysis in one day.
News & Technology Updates
Single-cell Analysis Reveals New Evolutionary Complexity in Uveal Melanoma
January 24, 2020 — Cell IDx is pleased to announce the co-authorship and inclusion of our UltraPlex mxIF technology in the University of Miami’s Nature Communications paper “Single-cell
analysis reveals new evolutionary complexity in uveal melanoma.”
Read the full paper on Nature’s website.
Tumor phenotyping in one step using a single small biopsy section to provide diagnostic, prognostic, and therapeutic indications.
Phenotype infiltrating T cell subpopulations, B cells, and antigen presenting cells, and quantitate expression of key molecules including checkpoint markers.
Highest sensitivity and specificity, low background secondary antibody HRP immunopolymers for all your IHC needs.
Custom multiplex panel development , and section
staining and imaging.
For Research Use Only. Not for use in diagnostic procedures.